CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CLX • US1890541097

121.45 USD
+1.86 (+1.56%)
At close: Feb 10, 2026
122.219 USD
+0.77 (+0.63%)
After Hours: 2/10/2026, 8:04:00 PM
Fundamental Rating

5

Overall CLX gets a fundamental rating of 5 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. CLX has only an average score on both its financial health and profitability. While showing a medium growth rate, CLX is valued expensive at the moment. Finally CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CLX had positive earnings in the past year.
  • CLX had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLX has been profitable.
  • CLX had a positive operating cash flow in each of the past 5 years.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • CLX has a better Return On Assets (13.45%) than 91.67% of its industry peers.
  • With an excellent Return On Invested Capital value of 21.55%, CLX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 14.75%.
  • The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROIC 21.55%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

  • CLX's Profit Margin of 11.17% is fine compared to the rest of the industry. CLX outperforms 66.67% of its industry peers.
  • CLX's Profit Margin has declined in the last couple of years.
  • CLX's Operating Margin of 15.21% is in line compared to the rest of the industry. CLX outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of CLX has declined.
  • CLX has a better Gross Margin (44.16%) than 66.67% of its industry peers.
  • CLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
  • The number of shares outstanding for CLX has been reduced compared to 1 year ago.
  • CLX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CLX is higher compared to a year ago.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • CLX has an Altman-Z score of 3.26. This indicates that CLX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CLX (3.26) is better than 75.00% of its industry peers.
  • The Debt to FCF ratio of CLX is 3.59, which is a good value as it means it would take CLX, 3.59 years of fcf income to pay off all of its debts.
  • CLX has a Debt to FCF ratio (3.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Altman-Z 3.26
ROIC/WACC2.7
WACC7.99%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • CLX has a Current Ratio of 0.74. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLX has a Current ratio of 0.74. This is amonst the worse of the industry: CLX underperforms 83.33% of its industry peers.
  • A Quick Ratio of 0.48 indicates that CLX may have some problems paying its short term obligations.
  • CLX has a Quick ratio of 0.48. This is amonst the worse of the industry: CLX underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.48
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • CLX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.48%.
  • CLX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.01% yearly.
  • The Revenue has decreased by -5.68% in the past year.
  • CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.11% yearly.
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%

3.2 Future

  • CLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.38% yearly.
  • CLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.40% yearly.
EPS Next Y-22.86%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
EPS Next 5Y2.38%
Revenue Next Year-7.99%
Revenue Next 2Y-1.73%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.51 indicates a rather expensive valuation of CLX.
  • The rest of the industry has a similar Price/Earnings ratio as CLX.
  • Compared to an average S&P500 Price/Earnings ratio of 28.03, CLX is valued a bit cheaper.
  • CLX is valuated rather expensively with a Price/Forward Earnings ratio of 17.84.
  • CLX's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, CLX is valued a bit cheaper.
Industry RankSector Rank
PE 18.51
Fwd PE 17.84
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 18.87
EV/EBITDA 13.54
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The decent profitability rating of CLX may justify a higher PE ratio.
  • CLX's earnings are expected to decrease with -2.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)18.27
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.15%, CLX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.50, CLX pays a better dividend. On top of this CLX pays more dividend than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

  • The dividend of CLX has a limited annual growth rate of 2.88%.
  • CLX has paid a dividend for at least 10 years, which is a reliable track record.
  • CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • CLX pays out 79.74% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of CLX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP79.74%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (2/10/2026, 8:04:00 PM)

After market: 122.219 +0.77 (+0.63%)

121.45

+1.86 (+1.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)02-03
Earnings (Next)05-04
Inst Owners89.77%
Inst Owner Change-2.2%
Ins Owners0.4%
Ins Owner Change13.57%
Market Cap14.68B
Revenue(TTM)6.76B
Net Income(TTM)755.00M
Analysts54.81
Price Target123.8 (1.93%)
Short Float %6.14%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP79.74%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-28
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.49%
Min EPS beat(2)-3.99%
Max EPS beat(2)6.97%
EPS beat(4)2
Avg EPS beat(4)5.85%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)6
Avg EPS beat(8)12.97%
EPS beat(12)10
Avg EPS beat(12)48.42%
EPS beat(16)13
Avg EPS beat(16)42.93%
Revenue beat(2)2
Avg Revenue beat(2)0.98%
Min Revenue beat(2)0.9%
Max Revenue beat(2)1.06%
Revenue beat(4)3
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)1.58%
Revenue beat(8)5
Avg Revenue beat(8)0.09%
Revenue beat(12)9
Avg Revenue beat(12)2.15%
Revenue beat(16)11
Avg Revenue beat(16)1.6%
PT rev (1m)-1.27%
PT rev (3m)-9.08%
EPS NQ rev (1m)-1.32%
EPS NQ rev (3m)-2.18%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-0.85%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 18.51
Fwd PE 17.84
P/S 2.17
P/FCF 18.87
P/OCF 14.92
P/B N/A
P/tB N/A
EV/EBITDA 13.54
EPS(TTM)6.56
EY5.4%
EPS(NY)6.81
Fwd EY5.61%
FCF(TTM)6.43
FCFY5.3%
OCF(TTM)8.14
OCFY6.7%
SpS55.89
BVpS-1.03
TBVpS-15.81
PEG (NY)N/A
PEG (5Y)18.27
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROCE 31.48%
ROIC 21.55%
ROICexc 23.01%
ROICexgc 49.39%
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
FCFM 11.51%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Debt/EBITDA 2.23
Cap/Depr 92.38%
Cap/Sales 3.05%
Interest Coverage 250
Cash Conversion 78.66%
Profit Quality 103.05%
Current Ratio 0.74
Quick Ratio 0.48
Altman-Z 3.26
F-Score6
WACC7.99%
ROIC/WACC2.7
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
EPS Next Y-22.86%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
EPS Next 5Y2.38%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%
Revenue Next Year-7.99%
Revenue Next 2Y-1.73%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.4%
EBIT growth 1Y-2.93%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.54%
EBIT Next 3Y7.17%
EBIT Next 5Y6.97%
FCF growth 1Y6.87%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y4.24%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 5 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 3 / 10 to CLOROX COMPANY (CLX). This can be considered as Overvalued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CLOROX COMPANY (CLX) stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CLX) is 18.51 and the Price/Book (PB) ratio is -117.48.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 79.74%.